For example, in breast, kidney or lung cancer cells, MMP9 (matrix metalloproteinase 9) and ADAM19 (Adam metallopeptidase 19) metalloproteinase expression during EMT are modulated by changes in histone methylation marks [144]. Here, MMP9 is linked to lung carcinoma.